LEXINGTON, Ky. (WKYT) - This year, health experts say 21,000 women will be diagnosed with ovarian cancer. It is often called a silent killer of women, but a free screening program through UK ...

UAB Medicine is pleased to announce the UAB Comprehensive Ovarian Cancer Program. Our mission is to improve the lives of women at risk for, or affected by ovarian cancer through a personalized ...

Nuvectis Pharma has dropped plans to develop NXP800 in ovarian cancer after tallying two unconfirmed partial responses in a phase 1b study. NXP800, a GCN2 kinase activator, has been on shaky ground ...

BriaCell Therapeutics is developing a new ovarian cancer immunotherapy candidate built on the same cell therapy platform used in its breast cancer program. The clinical stage immuno-oncology-focused ...

ETX-19477 demonstrated robust efficacy, with a 57% objective response rate in BRCA-mutated platinum-resistant ovarian cancer and earlier-line HR+/HER2- breast cancer (n=7) ---- Favorable safety ...

Three women who’ve survived ovarian cancer spent time sharing their story with future physician assistant students this summer at St. Scholastica. It’s part of MOCA’s Survivors Teaching Students ...

Ovarian Cancer Research Alliance partnered with Downstate Medical School to teach health care students things they won't learn in a textbook. Volunteers spoke on their survivor stories, identifying ...

Expanded niraparib ovarian cancer program intended to potentially transform the treatment of front-line ovarian cancer New breast cancer clinical program for niraparib to address greatest area of ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...